You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 4051 to 4075 of about 5948
Next 25
04/20/2007
Added: CDX-110 to list of brain tumor treatments
Malignant Glioma Cells Counteract Antitumor Immune Responses through Expression of Lectin-Like Transcript-1.
Correlation between O6-methylguanine-DNA methyltransferase and survival in inoperable newly diagnosed glioblastoma patients treated with neoadjuvant temozolomide.
AstraZeneca brain tumor drug shows promise
Antiangiogenic Agent Shows Promise against Glioblastoma
Reduced survivin expression and tumor cell survival during chronic hypoxia and further cytotoxic enhancement by the cyclooxygenase-2 inhibitor celecoxib.
New vaccine trial for newly diagnosed glioblastoma multiforme
No Generic Substitution of AEDs (anti seizure drugs) Without Physician and Patient Consent, Says AAN
04/19/2007
Race for Hope - Washington, DC May 6, 2007
Data From Investigator-Sponsored Trial of Oncophage® Cancer Vaccine in Glioma Presented at American Association of Neurological Surgeons Annual Meeting
04/18/2007
A novel lipoxygenase inhibitor Nordy attenuates malignant human glioma cell responses to chemotactic and growth stimulating factors.
Gefitinib in patients with progressive high-grade gliomas: a multicentre phase II study by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).
A phase I/II study of lomustine and temozolomide in patients with cerebral metastases from malignant melanoma.
Irinotecan: a potential new chemotherapeutic agent for atypical or malignant meningiomas.
Phase II study of imatinib mesylate and hydroxyurea for recurrent grade III malignant gliomas.
Gamma knife surgery for focal brainstem gliomas.
Canadian robot melds brain surgery, rocket science
Data Presented at AACR Meeting Show Peregrine`s Bavituximab Equivalent Can Generate Curative Immune Responses as Part of a Vaccine-Like Regimen in Preclinical Models of Aggressive Brain Cancer
Epidemiology of venous thromboembolism in 9489 patients with malignant glioma.
Myriad Genetics Presents Azixa`s Mode of Action at AACR
NICE finally approves glioma drugs after finding error in its calculations
YM BioSciences` partner Daiichi Sankyo receives clearance for initial clinical trial in Japan
Tapestry Pharmaceuticals Presents Data on TPI 287 at the AACR Annual Meeting 2007
Establishment of experimental glioma models at the intrinsic brainstem region of the rats.
Risk of malignancy after gamma knife stereotactic radiosurgery.